Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPH.L Regulatory News (MPH)

  • There is currently no data for MPH

Director Shareholding

24 Feb 2005 07:04

Marchpole Holdings PLC24 February 2005 24 February 2005 Marchpole Holdings plc (the 'Company') Directors' interests Following approval by the Remuneration Committee, the executive Directors of theCompany have been granted the following share options ('Options') over newordinary shares of 1 pence each ('Ordinary Shares') under the Marchpole Holdingsplc 2002 Unapproved Share Option Scheme adopted by the Company at the AnnualGeneral Meeting held on 31 October 2002. All Options were granted on 21 February 2005, are exercisable at a price of25.75 pence per share and vest and become exercisable in three equal tranches onand from each twelfth month anniversary of the date of grant on the attainmentof a market capitalisation of the Company of £60 million, £70 million and £80million respectively. Director Number of Options over new Ordinary SharesGreg Tufnell, Chief Executive 900,000Justin Hampshire, Finance Director 900,000Michael Morris, Executive Director 900,000 The additional grant of 3,250,000 Options in the Company has been made toMichael Morris at a exercise price of 25.75 pence per share, such share optionsvesting and becoming exercisable in two equal tranches on each twelfth monthanniversary on the date of grant and on the achievement of a marketcapitalisation of the Company of £50 million and £55 million respectively. The Directors have the following interests in the Company: Director Number of Ordinary % of issued Shares share capital Christopher Phillips, Chairman 500,000 0.38Greg Tufnell, Chief Executive - -Justin Hampshire, Finance Director 500,000 0.38Michael Morris, Executive Director 25,521,715 19.21Raymond Harris, Non-Executive Director 30,000 0.02 The Michael Morris 1997 Trust 10,000,000 7.55 Enquiries: Justin Hampshire, Marchpole Holdings 020 7908 7777 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
4th May 20177:00 amRNSInitiation of BPS-804 Phase 2b study
28th Apr 20173:37 pmRNSHolding(s) in Company
28th Apr 201712:53 pmRNSHolding(s) in Company
28th Apr 201710:05 amRNSHolding(s) in Company
26th Apr 20177:00 amRNSConversion of loan note and issue of equity
24th Apr 20176:07 pmRNSHolding(s) in Company
5th Apr 20177:00 amRNSGrant of Options and Awards
3rd Apr 20177:00 amRNSResults of Placing
31st Mar 20175:54 pmRNSResults of Placing
29th Mar 201712:30 pmRNSProposed Placing
15th Mar 20177:00 amRNSPosting of Annual Report and Notice of AGM
7th Mar 20177:00 amRNSPositive recommendation for BGS-649 Phase 2b trial
27th Feb 20177:00 amRNSPreliminary Results
20th Feb 20177:00 amRNSEMA Adaptive Pathways programme accepts BPS-804
23rd Jan 20177:05 amRNSPresentation at Shares Spotlight Evening
23rd Jan 20177:00 amRNSThree abstracts accepted for ATS Meeting
12th Jan 20177:01 amRNSDirectorate update
5th Jan 201712:00 pmRNSMereo BioPharma to Present at Biotech Showcase
12th Dec 20167:00 amRNSBusiness Update
7th Nov 20167:10 amRNSAppointment of Chief Financial Officer
3rd Nov 20167:00 amRNSPositive Phase 1 interaction study with BCT-197
5th Oct 20167:00 amRNSDirectorate Change
16th Sep 20167:00 amRNSHalf-year Report
9th Aug 20164:04 pmRNSNotice of Results
18th Jul 20161:25 pmRNSResult of AGM
30th Jun 20167:00 amRNSBPS-804 granted EU orphan drug status
24th Jun 201612:47 pmRNSNotice of AGM
9th Jun 20161:17 pmRNSDirector/PDMR Shareholding
9th Jun 20168:01 amRNSFirst Day of Dealings on AIM
10th Nov 20086:21 pmRNSFurther re financial position
4th Nov 20083:01 pmRNSStatement re suspension
4th Nov 20083:00 pmRNSSuspension
23rd Oct 20084:35 pmRNSHolding(s) in Company
23rd Oct 20082:25 pmRNSAGM Statement
2nd Oct 20083:14 pmRNSHolding(s) in Company
23rd Sep 200810:02 amRNSNotice of AGM
1st Sep 200810:06 amRNSHolding(s) in Company
29th Aug 20083:20 pmRNSResult of GM and Interim Mana
26th Aug 200810:13 amRNSHolding(s) in Company
19th Aug 20082:22 pmRNSHolding(s) in Company
14th Aug 20084:23 pmRNSHolding(s) in Company
13th Aug 200811:00 amRNSDirectorate Change
8th Aug 200811:14 amRNSHolding(s) in Company
8th Aug 200811:03 amRNSHolding(s) in Company
7th Aug 20084:46 pmRNSHolding(s) in Company
6th Aug 20084:41 pmRNSSecond Price Monitoring Extn
6th Aug 20084:36 pmRNSPrice Monitoring Extension
6th Aug 20083:17 pmRNSDirector/PDMR Shareholding
6th Aug 20087:08 amRNSFundraising and New Board App
6th Aug 20087:05 amRNSNew Joint Venture

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.